Skip to content
  • Sunday, 26 July 2026
  • 3:20 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Arc Mediates Intercellular Tau Transmission via Extracellular Vesicles and Represents a Potential Target for Slowing Alzheimer’s Progression
Neuroscience & Brain Research

Arc Mediates Intercellular Tau Transmission via Extracellular Vesicles and Represents a Potential Target for Slowing Alzheimer’s Progression

Rifan Muazin Jul 8, 2026 0

In a significant breakthrough for neurodegenerative research, scientists have identified a surprising biological mechanism that facilitates the spread of Alzheimer’s…

Read More
Laboratory Automation & Robotics

Pioneering Immune-Based Therapies: How NK Cell-Derived Extracellular Vesicles Offer New Hope for Traumatic Brain Injury and Alzheimer’s Disease

Lana Keisha Jul 3, 2026 0

Traumatic brain injury (TBI) stands as a formidable global health crisis, impacting an estimated 69 million individuals each year with…

Read More
Biotech & Genetic Research

Nature-Inspired Precision: International Study Unveils Targeted Gene Therapy Delivery Using Specific Extracellular Vesicles

Jia Lissa Apr 25, 2026 0

A groundbreaking international study, spearheaded by researchers from the University of Ottawa Faculty of Medicine in Canada, has introduced a…

Read More
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’Rethinking evidence generation for ultra-rare diseasesTop Automated Dispensing Cabinets for Pharmacies: Leading Brands ComparedThe Self-Hosted LLM Conundrum: Navigating the Real-World Obstacles of Local AI Deployment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ